| Entry |
|
|---|
| Name |
Bemoradan (USAN/INN) |
|---|
| Formula |
C13H13N3O3
|
|---|
| Exact mass |
259.0957
|
|---|
| Mol weight |
259.2606
|
|---|
| Structure |
|
|---|
| Class |
Cardiovascular agent
DG01703 Cardiotonic
DG01758 Pimobendan type cardiotonic
DG01507 Phosphodiesterase III inhibitor
DG01758 Pimobendan type cardiotonic
|
|---|
| Efficacy |
Cardiotonic, Phosphodiesterase inhibitor |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Cardiovascular agent
DG01703 Cardiotonic
DG01758 Pimobendan type cardiotonic
D03075 Bemoradan
DG01507 Phosphodiesterase III inhibitor
DG01758 Pimobendan type cardiotonic
D03075 Bemoradan
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Phosphodiesterases
PDE
D03075 Bemoradan (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 19
1 C8y C 21.2541 -17.5243
2 O2x O 22.5204 -18.2981
3 C8y C 21.2541 -16.1173
4 C8x C 20.0582 -18.2278
5 C1x C 23.7163 -17.5946
6 C8x C 20.0582 -15.4138
7 N1x N 22.5204 -15.4842
8 C8y C 18.8623 -17.5243
9 C5x C 23.7163 -16.1877
10 C8x C 18.8623 -16.1173
11 C2y C 17.5960 -18.2278
12 C1y C 16.4001 -17.5243
13 O5x O 24.9122 -15.4842
14 C1x C 15.1820 -18.2144
15 C5x C 15.1706 -19.6143
16 N1x N 16.3665 -20.3178
17 N2x N 17.5846 -19.6277
18 C1a C 16.4120 -16.1004
19 O5x O 13.9733 -20.2926
BOND 21
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 1
5 3 6 1
6 3 7 1
7 4 8 2
8 5 9 1
9 6 10 2
10 8 11 1
11 7 9 1
12 8 10 1
13 11 12 1
14 9 13 2
15 12 14 1
16 14 15 1
17 15 16 1
18 16 17 1
19 11 17 2
20 12 18 1
21 15 19 2
|
|---|
